Generic GLP-1 launch in US: Q2 2026
73%YES chance
Yes
73%
No
27%
Now 72.8%
Resolution
Resolves to the quarter the first FDA-approved generic GLP-1 (semaglutide or tirzepatide) launches in the US.
Source: https://www.fda.gov/
Resolves by May 23, 2027.
Recent trades
- YES@kaiunderhill50 sh@ 73%36 SP
- YES@rowandiaz83.6 sh@ 71%58 SP
- YES@parkerokafor39.5 sh@ 54%21 SP
- YES@logantorres92.7 sh@ 68%61 SP
- YES@finleyyoon104.2 sh@ 64%64 SP
- NO@audenpark175.8 sh@ 59%65 SP
- YES@sageunderhill97.2 sh@ 67%63 SP
- YES@logantorres43.1 sh@ 52%22 SP
- YES@sashavargas113.3 sh@ 63%68 SP
- YES@alexalvarez70.1 sh@ 57%39 SP
- YES@skylercarrillo160.4 sh@ 54%80 SP
- NO@kaipatel159.6 sh@ 46%80 SP
- NO@harperyoon192.8 sh@ 54%80 SP
- YES@grayhale93.6 sh@ 63%57 SP
- NO@alexalvarez177.2 sh@ 59%66 SP
- YES@frankieblake112.1 sh@ 67%72 SP
- YES@sagecarrillo73.3 sh@ 62%44 SP
- YES@juneyoon85.4 sh@ 58%48 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.
Discussion
- @kaiunderhillKai Underhilllast month
loaded up, the data is there.